Maryland Drugmaker Warned on Sterility

Drug Industry Daily
A A
Sterility concerns and other deficiencies at a Maryland drugmaker could be putting patients at risk, the FDA told Option Care Enterprises in Columbia, Md. in a July 20 warning letter.

To View This Article:

Login

Subscribe To Drug Industry Daily